Cover Image


Pharmaceutical Business Confidence Report Q4 2014

出版商 GlobalData 商品編碼 290628
出版日期 內容資訊 英文 73 Pages
Back to Top
全球醫藥品產業的景氣分析(以季度為基礎) Pharmaceutical Business Confidence Report Q4 2014
出版日期: 2014年11月29日 內容資訊: 英文 73 Pages





第1章 經濟分析

  • 分析方法和標本尺寸
  • 景氣現況
  • 成長預測與消費者信心指數
  • 供給者價格與支出水準
  • 組織的未來展望與策略
  • 附錄
Product Code: KG4330PR


"Pharmaceutical Business Confidence Report Q4 2014" is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the pharmaceutical industry over October-December 2014. This report also examines executive opinions with regards to the current and future state of the economy and its effect on the industry. It analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry. Furthermore, this report provides an overview of the key priorities, threats, and opportunities for the global pharmaceutical industry. In addition, the report includes the forecasts of the projected investments on pharmaceutical equipment, procurement budget allocations and the leading suppliers of pharmaceutical equipment in the pharmaceutical industry.

Key Findings

Overall, 46% of pharmaceutical industry respondents state that they are operating in a stable economic environment, while 42% state that their current economic conditions are favorable

The majority of global pharmaceutical industry respondents anticipate positive growth for both their companies and the industry over October-December 2014

Industry respondents from Asia-Pacific expect the highest growth in staff headcount and sales volume in October-December 2014

Improving operational efficiency and protecting and growing market share are the most popular priorities by pharmaceutical industry executives operating across all regions

Highest percentage, 79%, of the survey respondents operating in Europe gives high preference for outright purchase in Q4 2014, while 21% of the respondents show less preference

Respondents intend to allocate the biggest part of their procurement budget towards meeting operating expenses in 2015

Survey results indicated that 35% of the survey respondents invest on the laboratory instrument every year.


This report is the result of an extensive survey drawn from Kable's exclusive panel of leading global pharmaceutical industry executives. The report analyzes current global economic conditions and their impact on the pharmaceutical industry, and forecasts the company and industry growth prospects over October-December 2014. It provides information about the impact of customer confidence, supplier prices, and staff headcount likely to affect investment decisions October-December 2014. Additionally, the report includes the trends in the pharmaceutical equipment market, analysis of the procurement budget allocations and leading suppliers of pharmaceutical equipment.

In particular, it provides an in-depth analysis of the following:

Industry executives' opinions about the current state of the global economy, examining the prevailing economic conditions and executives' opinions with regards to the global economy and the state of economic conditions in various regions

The growth prospects of companies and the industry as a whole, providing industry executives' expectations on the growth prospects of their company and the Industry over October-December 2014

Change in customer confidence, analyzing pharmaceutical industry executives' opinions on changes in customer confidence globally, over October-December 2014

Impact of supplier prices, determining the expected change in supplier prices across various categories and their impact on business confidence, and examines the key factors influencing the change

Change in staff headcount and sales performance, tracking the expected changes in staff headcount and sales among industry executives operating in various regions, over October-December 2014

Investment activities, ascertaining the various investment activities on which industry executives intend to focus on over October-December 2014

Business concerns, examining industry executives' attitudes towards various business concerns and provides regional analysis

Key priorities, identifying the immediate business priorities of pharmaceutical industry executives over October-December 2014

Purchase preferences: analyzing the purchasing behavior towards pharmaceutical equipment and investment allocations in the pharmaceutical equipment categories

Budget allocation: examining total procurement budget split between capital expenditure and operating expenditure, and tracking the changes in the budget for 2014 and expectations for 2015.

Reasons To Buy

The report projects the current and future operating conditions of the pharmaceutical industry, and allows readers to make effective business decisions

The report helps readers make strategic decisions by understanding the present and future economic and customer issues, including key growth regions

Pharmaceutical industry suppliers will be provided with a clear uncovering of the key challenges and opportunities, and identify the key priorities likely to affect the industry's growth prospects

The report forecasts the change in supplier prices of various products, which are likely to influence the industry's growth prospects over October-December 2014

The report helps executives to recognize the change in customer confidence levels in the global pharmaceutical industry over October-December 2014

The report enables the executives to take key decisions on purchase preferences and investments in pharmaceutical equipment.

Table of Contents

  • Methodology and sample size
  • Confidence indexes
  • State of the economy
  • Growth prospects and customer confidence
  • Supplier prices and levels of expenditure
  • Organizational outlook and strategy
  • Procurement budget and expenditure outlook
  • Appendix
Back to Top